M
BLUE

Murchinson’s bluebird bio BLUE Stock Holding History

Murchinson’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,000
Closed -$254K – 66
2025
Q1 		$254K Buy
+52,000
New +$313K 0.01% 78

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Murchinson's BLUE Position: Q2 2025 in Review

Murchinson sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 52,000 shares — an estimated $254K sold.

Murchinson first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $254K in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Murchinson reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Murchinson sold 52,000 bluebird bio shares in Q2 2025, an estimated $254K.
  • Murchinson first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
  • Murchinson's bluebird bio position peaked at $254K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Murchinson's 13F filing for Q2 2025, filed 14 Aug 2025.